key: cord-0714294-ri4otc7w authors: Smith, L.; Elwick, H.; Mhizha-Murira, J.R.; Topcu, G.; Bale, C.; Evangelou, N.; Timmons, S.; Leighton, P.; das Nair, R. title: Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners date: 2020-10-04 journal: Mult Scler Relat Disord DOI: 10.1016/j.msard.2020.102563 sha: 45fd4154cd69e83b868dc1480d9ae792211b8506 doc_id: 714294 cord_uid: ri4otc7w Background: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. We collected and synthesised stakeholder perspectives to develop a care pathway for cognitive problems in MS and produce a logic model, illustrating how this pathway might operate. Methods: Forty-nine stakeholders, including people with MS and care providers, participated in semi-structured interviews and focus groups. Participants viewed information that illustrated how the pathway might work and provided feedback. Data, transcribed verbatim and analysed using Framework Analysis, were mapped onto a preliminary logic model and accompanying thematic framework. Results: The proposed pathway was perceived as helpful in providing standardised support for a neglected MS symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities. Shared responsibility, a person-centred approach, and addressing the complexity of cognitive problems were important engagement mechanisms. Allocating time during clinic appointments and within staff workloads were essential resources for implementation. Conclusion: Our co-constructed MS cognitive screening and management pathway will be evaluated for clinical and cost-effectiveness in a trial. However, in the interim, clinicians can adapt and implement this pathway in their own services and evaluate it locally. • No established care pathway exists for screening and managing cognitive problems. • Based on stakeholder interviews, we developed a logic model for the pathway. • The logic model illustrates how a new clinical care pathway could work. • To work, the pathway relies on shared responsibility and a person-centred approach. Cognitive problems affect up to 70% of people with MS (pwMS) (1) and can negatively impact quality of life and vocational activities (2) (3) (4) . Consequently, routine screening and management for cognitive problems in MS has been internationally recommended (5, 6) , with addressing cognitive problems a 'top 10' research priority for pwMS (7) . Despite these calls to action, UK MS services do not have an established care pathway which integrates these recommendations. A UK-wide survey of clinicians found variation in cognitive assessments used, often with inappropriate screening tools used rather than the recommended tests (8) . We also found a lack of consistency in reporting cognitive rehabilitation interventions, particularly regarding the content of interventions and their underlying framework (9) . These issues make it difficult for healthcare services to consistently and systematically implement cognitive screening and rehabilitation (10) . To address this gap, we aimed to develop a multi-agency, co-constructed, clinical pathway to forge a consensus on screening and managing cognitive problems in MS and how to go about this. Medical Research Council (MRC) guidelines stress the importance of theory in developing and evaluating complex interventions (11) . Here we propose an initial logic model ( Figure 1 ) which depicts the theory underpinning a screening and management pathway for cognitive problems in MS. Our model was informed by literature reviews (12) (13) (14) , theory (e.g., Behaviour Change Wheel (15) ), Patient and Public Involvement (PPI), clinical experience, and service realities. It adopts a Situation-Inputs-Outputs-Mechanism-Outcome configuration (16) . Situation describes the contextual features that pre-date the introduction of the pathway; including the high prevalence of cognitive problems, lack of standardised screening and support for cognitive problems (particularly mildmoderate problems (17, 18) , and healthcare recommendations which drive the focus of clinical care (e.g., NICE -recommends screening and managing cognitive problems, but is not based on robust evidence and does not refer to a particular assessment or treatment (19) ). Inputs are the resources required to support the pathway. Outputs describe the products created by the activities of the pathway. Mechanisms are mediating factors and obstacles between the introduction of the pathway and the resulting outcomes (e.g., stakeholders need to be engaged and supported; and the pathway accessible and flexible for implementation). Outcomes describe what results from the pathway. The specifics of these factors can be found in Figure 1 . Logic models are dynamic, they represent working hypotheses and are modified iteratively as new insights emerge based on primary (e.g., stakeholder consultation, evaluation studies) or secondary data (e.g., existing literature/policy) (20) . Conducting primary research with key stakeholders can enhance theoretical understanding of the processes of change (21) . Exploring the views of key stakeholders at an early stage also helps to produce a co-constructed output (22) that empowers and engages stakeholders (23) . Here, stakeholder perspectives were used to develop a multi-agency cognitive screening and management pathway. This study is part of the NEuRoMS project (24) which will evaluate the efficacy of this pathway across six UK MS clinics. <> Figure 1 . Initial Logic Model. Ethical approval was granted by the University of Nottingham Faculty of Medicine and Health Sciences Ethics Committee (reference: 263-1903). All participants provided informed consent prior to data collection. We sought to interview a broad range of stakeholders with complementary perspectives on a screening and management pathway for cognitive problems, we selected purposively from those willing to be interviewed to generate this. Participants were contacted by email or phone and invited to a focus group or an interview (in-person, or via telephone/video conferencing), based on their preference. Semi-structured interviews were conducted by authors JMM, RdN, NE and HE (see Supplementary Materials for interview schedules). The focus group with pwMS was co-facilitated by our PPI partner CB, to enhance data richness (25) . Interviews were audio-recorded and transcribed verbatim. Participants were shown several resources to illustrate how the pathway might work and were asked to provide feedback. Making Test (32)); and, a self-report questionnaire (Multiple Sclerosis Neuropsychological Questionnaire (33)). The initial logic model ( Figure 1 ) was also shared. Anonymised transcripts were analysed on NVivo 12 using the Framework approach (34). The logic model informed a working analytical framework (see Figure 1 and Supplementary Materials for coding scheme) and data were mapped onto this. Review of the mapped and organised data informed a revision of the logic model based on the findings below. Yardley's evaluative characteristics for good qualitative research were applied (35) . Regular team discussions were also held to modify the coding scheme to better represent the data (36) . Summary data were presented to a PPI group to sensecheck our interpretations. Forty-four participants were interviewed (25- There was consensus on the current situation-cognitive problems were reported as prevalent and disruptive, and stakeholders recognised the need to address these problems using a standardised pathway. Discussions therefore focused on how the pathway would work. Data were organised into overarching themes (pre-defined logic model configurations), themes (core patterns) and sub-themes (further depth). Key results are presented for each overarching theme (inputs, outputs, mechanisms, outcomes) and supporting data are displayed in Tables 2-5 , with superscript numbers linking relevant quotes to the text. When multiple participant groups endorsed a sub-theme the term 'stakeholders' is used, otherwise the relevant group of stakeholders is specified (e.g., pwMS). Clinical Staff were recognised as an important resource. Stakeholders pointed to 'competition' between symptoms during clinic appointments, with limited time to address multiple MS symptoms 1 . Clinicians commented on the need to monitor drug treatments during the appointment, which took precedence over dealing with cognitive problems 2 . Physical symptoms including spasticity and bladder and bowel issues were often prioritised over cognitive problems 3 . Pressured workloads were also raised, particularly those of MS nurses 4 . Stakeholders reflected that any new pathway would impact on staff time 5 and that it is unclear who might have the capacity to deliver this 6 . PwMS thought they would need to expend mental and physical resources to engage in the pathway. Travelling to hospital requires time, effort and planning 7 . Digital technologies are also needed to access cognitive screening 8 . Further time commitments may be necessary from those attending multiple rehabilitation sessions 9 . Clinic facilities, including technology to host the cognitive screening (e.g., computer tablet, WiFi access 10 ), and a clinic room where screening and support sessions could be completed 11 , was also identified as a key resource. Clinicians and commissioners thought understanding existing costing and commissioning frameworks and having a strategy in place to show how the proposed pathway addresses these drivers 12 PwMS understood the relevance of the cognitive measures presented to them and thought these were appropriately challenging 8 . However, some found the mental arithmetic task (PASAT) unpleasant 9 . Everyone agreed that cognitive screening should be brief. Clinicians acknowledged the need to balance the sensitivity and brevity of screening tasks 10 . Clinicians thought that screening results should be digitised within patients' medical records 11 . They felt that the feedback report should include cut-offs to help identify individuals who may require support 12 and enable discussions around the type and severity of the cognitive problem 13 . Most stakeholders thought the results should be communicated face-to-face, at a routine clinical appointment, rather than over the telephone or via letter/email 14 . Communications should be initiated by a neurologist where problems are severe 15 . Stakeholders recognised the complexity of triage decisions and referrals. Where present, concurrent symptoms such as low mood and fatigue needed to be interpreted in relation to cognitive problems 16 . Stakeholders also highlighted the importance of the perspective of pwMS. Triaging should consider how the person was feeling during cognitive screening and any extenuating circumstances (e.g., relapse, technology problems 17 ) . Stakeholders thought that pwMS should engage in these discussions to reflect upon the functional impact of cognitive problems 18 . Data relating to the cognitive rehabilitation/management programme reiterated that concurrent symptoms need to be addressed by the pathway, through the provision of relevant information 19 . Stakeholders felt the content should include compensatory strategies that can be implemented at home 20 and gave examples of strategies they thought might work well (e.g., digital technologies 21 ) or be less effective (e.g., abstract visualisation 22 ). <> The complexity of cognitive problems was raised as an important mediator. Stakeholders highlighted the interdependence of symptoms and recognised that stress and fatigue can exacerbate cognitive problems 1 . Similarly, cognitively demanding activities left pwMS feeling fatigued and drained 2 . Stakeholders thought the pathway should recognise that some cognitive problems will stem from brain damage driven by MS, whilst others are a secondary reaction to living with MS 3 . Clinicians thought this was an important distinction to recognise 4 . Stakeholders suggested the pathway should also acknowledge that individual differences could influence cognitive performance and the effectiveness of support programs, and the perspective of related informants need to be addressed 5, 6 . Stakeholders felt pwMS should be informed about the rationale for the pathway. Explanations should reassure them that the pathway is meaningful 7 and clarify how it will inform their clinical care 8 . Stakeholders thought information should be clearly communicated avoiding medical jargon 9 . The timing of the pathway is an important mediator for pwMS. Stakeholders thought invitations to complete the screening should be aligned with a routine appointment where the results can be communicated without delays 10 . Most pwMS supported the idea of being told about the screening tool in advance of their appointment 11 but acknowledged some might worry about this 12 . Some thought receiving information about the pathway might overwhelm newly diagnosed patients 13 , while others felt cognitive problems should form part of these early conversations 14 . Stakeholders indicated that home-based approaches (e.g., online screening, telephone follow-ups for the cognitive management programme) would be convenient and less stressful for most pwMS 15 , particularly those in employment who cannot attend multiple appointments 16 . However, home-based approaches were not perceived as feasible for all 17 ; stakeholders thought access to additional support (telephone or face-to-face in-clinic) would promote engagement 18 . Engaging clinical staff encompassed clinicians' reflections on which team members they thought responsible for addressing cognitive problems. Some thought MS nurses and neurologists would not consider cognitive problems as part of their The pathway should empower pwMS to be proactive and to take actions which target milder cognitive problems 29, 30 . However, stakeholders also acknowledged some pwMS will not be motivated to engage with this because of fatigue and cognitive problems 31 . PwMS thought the pathway should promote a positive outlook and inspire them 32, 33 . However, clinicians recognised the need to manage expectations, e.g. manage problems rather than restore abilities 34, 35 . These discussions can be frustrating for pwMS who want their cognitive abilities restored 36 . Stakeholders thought appropriate information might temper unrealistic expecations 37 . <
> We elicited 'short-term' outcomes of the pathway from the data, including improved access to standardised clinical care for cognitive problems. Clinicians spoke about the lack of formalised guidelines for MS services 1 and thought the pathway would address this 2 . Clinicians and commissioners felt the pathway would facilitate conversations about cognitive problems by providing information about patients' symptoms 3, 4 . These conversations were also perceived positively by pwMS 5 , who valued the opportunity to discuss cognitive problems 6 and have their concerns validated 7, 8 . Some stakeholders acknowledged that anticipating the screening results could worry pwMS 9 . Moreover, being reminded of symptoms and noticing cognitive decline might be upsetting 10, 11 . Consequently, some pwMS may disengage with the pathway 12 . 'Longer-term', stakeholders thought being able to understand and manage cognitive problems would improve quality of life amongst pwMS 13, 14 . Earlier detection and management of problems might even prevent deterioration 15 and prolong independence 16 . Stakeholders indicated that early detection and management could promote efficient use of NHS resources 17, 18 . Home-based cognitive screening was also considered efficient, reducing the time required with a clinician 19 . Stakeholders reflected on a potential increase in referrals to psychological services 20 , which could overwhelm already pressured services 21 . <
> Stakeholder feedback confirmed that staff time, training packages, brief online screening tasks, and person-centred support for cognitive problems are important elements in the pathway. Improved access to care and clearer referral pathways for cognitive problems were still thought of as possible outcomes (as in Figure 1 ). However, our data also offers new insights that challenge the initial logic model and enabled us to consider implementation more directly. Figure 2 reflects a revised logic model that could inform subsequent service development. <